CLINICAL_TRIALS trial_result · 2022-03-22

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema [Phase 3]

Phase 3 trial evaluating Faricimab for Diabetic Macular Edema has completed and results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2022-03-22